J&J | Los Gastos De Explotación



Operating Expenses Cambio Fecha
AbbVie USD 9.61B 6.98B 2025-03
Abbott USD 8.7B 363M 2025-03
Amgen USD 6.86B 85M 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Baxter International USD 3.19B 644M 2024-12
Bayer EUR 11.41B 3.22B 2025-03
Becton, Dickinson and Co. USD 4.73B 11M 2025-03
Biogen USD 2.12B 106.5M 2025-03
Boston Scientific USD 3.74B 144M 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
CONMED USD 305.3M 11.85M 2025-03
Cooper Companies USD 782.7M 37.3M 2025-01
Dexcom USD 902.3M 22.3M 2025-03
Edwards Lifesciences USD 1.02B 55.3M 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Globus Medical USD 501.12M 95.9M 2025-03
Hologic USD 1.01B 220.3M 2025-03
Indivior 200M 193M 2025-03
Insulet USD 519.7M 31.5M 2025-03
Integra LifeSciences USD 398.61M 8.81M 2025-03
Intuitive Surgical USD 1.68B 3.3M 2025-03
J&J USD 8.26B 10.37B 2025-03
Medtronic USD 7.49B 845M 2025-04
Merck USD 9.66B 1.67B 2025-03
Merit Medical Systems USD 314.32M 4.28M 2025-03
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
Stryker USD 5.03B 826M 2025-03
Tandem Diabetes Care USD 355.3M 72.07M 2025-03
Teva Pharmaceutical Industries USD 3.37B 402M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12
Zimmer Biomet Holdings USD 1.63B 89.5M 2024-12
Zoetis USD 1.41B 175M 2025-03



J&J Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.